TGA Approval

DEPROCIP medroxyprogesterone acetate 150 mg/1 mL injection suspension vial (318838)

ARTG ID

318838

ARTG Name

DEPROCIP medroxyprogesterone acetate 150 mg/1 mL injection suspension vial

Sponsor

Cipla Australia Pty Ltd

ARTG Date

May 13, 2020

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

CIPLA AUSTRALIA PTY LTD

Ingredient Name

medroxyprogesterone acetate

Empowering clinical research with data-driven insights and AI-powered tools.